68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only(Expired)

Dates

Bid Notification started - 22 May, 2017 (18 months ago) - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Start Date

22 May, 2017 (18 months ago)
Bid Notification due - 22 May, 2017 (18 months ago) - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Due Date

26 May, 2017 (18 months ago)
Bid Notification - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Opportunity Type

Bid Notification
VA25817N0483 - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Opportunity Identifier

VA25817N0483
Bid Notification Department of Veterans Affairs - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Customer / Agency

Department of Veterans Affairs
Bid Notification VA Cooperative Studies;2401 Centre Avenue SE;Albuquerque NM 87106 87106 USA - 68--VA258-17-N-0483 AVICEL PH302 Pharmaceutical Chemical Name Brand Only

Location

VA Cooperative Studies;2401 Centre Avenue SE;Albuquerque NM 87106 87106 USA
From: Federal Government(Federal)
Added:
May 22, 2017 8:48 pm [Type the author name]
Sources Sought Notes
This is a SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Service Disabled Veteran Owned Small Businesses and Veteran Owned Small Businesses interested and capable of providing the services described below. Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. Responses to this notice shall include the following: (a) company name (b) address (c) point of contact (d) phone, fax, and email (e) DUNS number (f) Cage Code (g) Tax ID Number (h) Type of small business, e.g. Services Disabled Veteran Owned small Business, Veteran-owned small business and (i) must provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described below.
Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. The VA is mandated by Public Law 109-461 to consider a total set-aside for Service Disabled Veteran Owned Small Business set aside. However, if response by Service Disabled Veteran Owned Small Business firms proves inadequate, an alternate set-aside or full and open competition may be determined. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 325998 (500 employees).

Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). Additionally, all Service Disabled Veteran Owned Businesses or Veteran Owned Businesses who respond to a solicitation on this project must be registered with the Department of Veterans Affairs Center for Veterans Enterprise VetBiz Registry located at http://vip.vetbiz.gov. All interested Offerors should submit information by e-mail to. All information submissions shall be received no later than 5:00 pm Eastern Time on May 26, 2017. After review of the responses to this announcement, the Government intends to proceed with the acquisition and a subsequent solicitation may be published.
Date of Response: May 26, 2017
Time of Response: no later than 5:00 pm Eastern Time
Responses shall be sent by electronic mail to POC: at Theresa.hamilton@va.gov


STATEMENT OF WORK (SOW)
Avicel PH-302, NF

SCHEDULE OF SERVICES AND/OR SUPPLIES.

Line Item #
Item/Stock#
Description
Est. Qty.
Unit
1
PH302-NFDR050I
Avicel PH 302, NF, 50 kg per drum
5
DR
2

Estimated S&H
1
EA

BACKGROUND.

The VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (CSPCRPCC) needs to purchase Avicel PH-302, NF, a proprietary high grade, high density, pharmaceutical grade microcrystalline cellulose, for the manufacture of tablets and capsules used for RESEARCH PURPOSES in veteran patient clinical trials:
CSP590 - Double Blind Placebo Controlled Study of Lithium For Preventing Repeated Suicidal Self-Directed Violence in Patients with Depression or Bipolar Disorder, and
CSP594 - Comparative Effectiveness in Gout: Allopurinol versus Febuxostat.

SCOPE.
Avicel PH-302 is proprietary microcrystalline cellulose, NF that is only manufactured by FMC Inc. This is a Brand Name Only request. Must be manufactured by FMC to maintain the consistency needed for the in progress research studies. It is the primary ingredient used to manufacture placebo tablets for CSP590 and CSP594. It is the primary excipient used in CSP594 allopurinol capsules. Both clinical trials are ONGOING.

We must use the same ingredients in the Products used in the Research Clinical Trials CSP594 and CSP590 each time we manufacture them. We previously manufactured Products which are currently being used in these clinical trials.

TASK
Task 1 Provide 250 kilograms of Avicel PH-302, NF and a Certificate of Analysis for the product. The Avicel PH-302 must meet the following:

Nominal Particle Size
Moisture
Loose Bulk Density
100 Âμm
3.0 to 5.0%
0.35 0.46 g/cc
It must exhibit the following characteristics:
High density
Maximize/high flow for capsule powder filling and direct compression
Low lubrication required
Excellent compression and compactability
Strong binder
Rapidly disintegrating for immediate release
Anti-adherent
Low tablet friability
High dilution potential (allows for higher drug levels)

SECURITY REQUIREMENTS.

The C&A requirements do not apply. A Security Accreditation Package is not required.

OTHER PERTINENT INFORMATION OR SPECIAL CONSIDERATIONS.
Identification of Possible Follow-on Work.
We expect to make additional purchases over the life of each study. Because the tablet and capsule requirements for a Research Clinical Trial change constantly, we cannot predict when we will need to buy additional Avicel PH-302. While we could use an IDIQ, it is difficult to predict the variations in the amount of material we will need each year.

The material has an expiration date. We prefer to not order excessively large quantities of the material at one time because it could expire before it can be used, wasting VA and taxpayer dollars.

Identification of Potential Conflicts of Interest (COI).
The CSPCRPCC is not aware of any conflicts of interest between its employees and the vendor.

RISK CONTROL.
Material will be inventoried and inspected upon delivery

PERIOD OF PERFORMACE.

Items shall be delivered 30 days ARO.

DELIVERY:

Deliverable Title
Format
Number
Calendar Days After CO Start
Receipt of 250 kilograms of Avicel PH-302, NF and Certificate of Analysis.
Packaged product
Five 50 kilogram drums of Avicel PH-302, microcrystalline cellulose, NF
Determined by availability. Typically 3 weeks from order placement

Items will be delivered to VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (CSPCRPCC) at the following address:
CSPCRPCC
2401 Centre Avenue, SE
Albuquerque, NM 87106-4180

Delivery will be made NLT (no later than) 30 days after award of contract but earlier is preferred.
VA shall not pay for freight charges exceeding $250.00, Per VAAR 847.303-1 F.O.B. origin.
A copy of a packing slip will be furnished at the time the order is delivered.



ACRONYMS.

Avicel PH-302, NF high density microcrystalline cellulose, NF used in the manufacture of tablets and capsules.

ARO- After Receipt of Order

CO Contracting Officer. The Federal employee who is warranted by the Government to enter into contracts on behalf of the Government and is the only person authorized to make changes to those contracts.

COR Contracting Officer s Representative. Individual designated by the CO to place orders, furnish technical guidance, advice, certify invoices, and provide general supervision of the work performed under the executed contract.

CSPCRPCC Cooperative Studies Program Clinical Research Pharmacy Coordinating Center.

FDA Food and Drug Administration

NF National Formulary a book of standards/specifications for pharmaceuticals and raw materials used in pharmaceuticals that are not included in the USP.

Excipient a pharmacologically inert substance, used as an ingredient of a tablet or capsule.

NMVAHCS New Mexico Veterans Affairs Healthcare System

VAMC Department of Veterans Affairs Medical Center

CSP590 - Double Blind Placebo Controlled Study of Lithium For Preventing Repeated Suicidal Self-Directed Violence in Patients with Depression or Bipolar Disorder, and

CSP594 - Comparative Effectiveness in Gout: Allopurinol versus Febuxostat

Location

Country : United States

State : New Mexico